Teleflex (NYSE:TFX) Sets New 52-Week Low - Time to Sell?

Teleflex Incorporated (NYSE:TFX - Get Free Report) shares reached a new 52-week low on Friday . The stock traded as low as $195.25 and last traded at $195.25, with a volume of 191714 shares. The stock had previously closed at $198.03.

Wall Street Analyst Weigh In

Several research firms recently issued reports on TFX. Stephens increased their price target on shares of Teleflex from $275.00 to $290.00 and gave the stock an "overweight" rating in a research report on Friday, August 2nd. Mizuho decreased their price target on Teleflex from $275.00 to $250.00 and set a "neutral" rating on the stock in a research note on Friday, November 1st. Needham & Company LLC restated a "hold" rating on shares of Teleflex in a research report on Friday, November 1st. Royal Bank of Canada reduced their price objective on Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a research note on Friday, November 1st. Finally, Truist Financial reissued a "hold" rating and set a $227.00 target price (down previously from $255.00) on shares of Teleflex in a research note on Monday. Four investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Teleflex currently has an average rating of "Moderate Buy" and an average price target of $259.25.

Teleflex Stock Performance

The company's 50-day moving average price is $235.39 and its two-hundred day moving average price is $223.70. The company has a market capitalization of $9.08 billion, a price-to-earnings ratio of 38.87, a PEG ratio of 2.07 and a beta of 1.18. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, topping the consensus estimate of $3.38 by $0.11. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $764.40 million during the quarter, compared to analyst estimates of $768.68 million. During the same period last year, the company posted $3.64 EPS. The business's quarterly revenue was up 2.4% on a year-over-year basis. On average, equities research analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.70%. The ex-dividend date of this dividend is Friday, November 15th. Teleflex's dividend payout ratio (DPR) is 27.04%.

Insider Activity at Teleflex

In other Teleflex news, Director Stuart A. Randle sold 2,674 shares of Teleflex stock in a transaction on Friday, August 16th. The shares were sold at an average price of $238.93, for a total value of $638,898.82. Following the completion of the sale, the director now directly owns 5,496 shares of the company's stock, valued at approximately $1,313,159.28. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.43% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Teleflex

Hedge funds and other institutional investors have recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. bought a new stake in Teleflex during the 1st quarter valued at $2,467,000. Nordea Investment Management AB raised its holdings in shares of Teleflex by 17.4% in the 1st quarter. Nordea Investment Management AB now owns 3,481 shares of the medical technology company's stock worth $782,000 after acquiring an additional 517 shares during the last quarter. Texas Permanent School Fund Corp lifted its position in Teleflex by 1.6% in the 1st quarter. Texas Permanent School Fund Corp now owns 9,714 shares of the medical technology company's stock valued at $2,197,000 after acquiring an additional 152 shares in the last quarter. Empirical Finance LLC boosted its stake in Teleflex by 3.9% during the 1st quarter. Empirical Finance LLC now owns 1,564 shares of the medical technology company's stock valued at $354,000 after purchasing an additional 58 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. increased its holdings in Teleflex by 10.7% during the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 1,648 shares of the medical technology company's stock worth $373,000 after purchasing an additional 159 shares in the last quarter. Institutional investors own 95.62% of the company's stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.